Sonnet BioTherapeutics Holdings, Inc. recently participated in the Virtual Investor "Top 5 for ‘25” On-Demand Conference, where CEO Pankaj Mohan, Ph.D., outlined five reasons for the ...

today announced it participated in the Virtual Investor "Top 5 for ‘25” On-Demand Conference. As part of the event, Pankaj Mohan, Ph.D., Founder and Chief Executive Officer of Sonnet ...

Raghu Rao, Interim Chief Executive Officer and Dr. Richard Kenney, Chief Medical Officer, of Sonnet discuss the recently announced safety data related to SON-1010 - Watch the "What This Means" video ...

Sonnet BioTherapeutics Holdings, Inc. is a clinical stage biotechnology company, which engages in the innovation of biologic medicines. Its Fully Human Albumin Binding (FHAB) technology utilizes a ...

Inc. (the“Company” or“Sonnet”) (NASDAQ: SONN), a clinical-stage company developing targeted immunotherapeutic drugs, today announced it participated in the Virtual Investor "Top 5 for '25 ...